OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00236056

Shanxi Tond Chemical Co Ltd

Commodity ChemicalsVerified

Shanxi Tond Chemical maintains a debt-to-equity ratio of 1.52, indicating a moderate reliance on debt financing relative to equity. The company's liquidity is assessed as medium, with negative net cash after subtracting total debt, suggesting potential pressure to manage short-term obligations. Operating cash flow of CNY 176.1 million supports ongoing operations, but capital expenditures of CNY -16.7 million indicate minimal investment in new capacity or asset upgrades. Profitability metrics show mixed performance. The company's operating cash flow is positive, but the absence of ROIC and margin data in the valuation snapshot limits direct comparison to industry benchmarks. Given the industry_config preference for ROIC and EBITDA margins in Commodity Chemicals, the lack of these metrics suggests a need for further scrutiny of operational efficiency and cost management. The company's revenue is concentrated in domestic markets, with no disclosed international exposure. Segment-wise, the Civil Explosives segment is the primary revenue driver, followed by the PBAT biodegradable plastics segment and the Other segment, which includes supply chain and power businesses. The lack of geographic diversification increases exposure to domestic economic and regulatory shifts. Outlook data is not provided, but the company's operating cash flow and debt levels suggest a cautious approach to growth. Without disclosed revenue growth rates or future projections, it is difficult to assess the trajectory of expansion or contraction. The absence of a clear growth narrative may indicate a stable but low-growth business model. Risk factors include medium liquidity risk due to negative net cash and a debt-to-equity ratio above 1.0. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the absence of detailed dilution rationales in the risk assessment limits the ability to fully assess capital structure stability. Recent events, including filings and transcripts, are not disclosed in the input data, preventing an assessment of management commentary or strategic shifts. The lack of recent disclosures may indicate a stable but uneventful operational environment.

30-day price · 002360-0.33 (-5.2%)
Low$5.73High$6.99Close$6.04As of15 May, 00:00 UTC
Profile
CompanyShanxi Tond Chemical Co Ltd
Ticker002360.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shanxi Tond Chemical Co Ltd produces and sells civilian explosives, biodegradable plastics, and provides engineering blasting services, primarily serving the mining and infrastructure construction sectors in China.

Classification. Shanxi Tond Chemical is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Shanxi Tond Chemical maintains a debt-to-equity ratio of 1.52, indicating a moderate reliance on debt financing relative to equity. The company's liquidity is assessed as medium, with negative net cash after subtracting total debt, suggesting potential pressure to manage short-term obligations. Operating cash flow of CNY 176.1 million supports ongoing operations, but capital expenditures of CNY -16.7 million indicate minimal investment in new capacity or asset upgrades. Profitability metrics show mixed performance. The company's operating cash flow is positive, but the absence of ROIC and margin data in the valuation snapshot limits direct comparison to industry benchmarks. Given the industry_config preference for ROIC and EBITDA margins in Commodity Chemicals, the lack of these metrics suggests a need for further scrutiny of operational efficiency and cost management. The company's revenue is concentrated in domestic markets, with no disclosed international exposure. Segment-wise, the Civil Explosives segment is the primary revenue driver, followed by the PBAT biodegradable plastics segment and the Other segment, which includes supply chain and power businesses. The lack of geographic diversification increases exposure to domestic economic and regulatory shifts. Outlook data is not provided, but the company's operating cash flow and debt levels suggest a cautious approach to growth. Without disclosed revenue growth rates or future projections, it is difficult to assess the trajectory of expansion or contraction. The absence of a clear growth narrative may indicate a stable but low-growth business model. Risk factors include medium liquidity risk due to negative net cash and a debt-to-equity ratio above 1.0. The company's dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the absence of detailed dilution rationales in the risk assessment limits the ability to fully assess capital structure stability. Recent events, including filings and transcripts, are not disclosed in the input data, preventing an assessment of management commentary or strategic shifts. The lack of recent disclosures may indicate a stable but uneventful operational environment.
Key takeaways
  • The company's debt-to-equity ratio of 1.52 suggests a moderate reliance on debt financing.
  • Operating cash flow is positive, but capital expenditures are minimal, indicating limited investment in growth.
  • Revenue is concentrated in domestic markets, increasing exposure to local economic and regulatory risks.
  • The company's liquidity is assessed as medium, with negative net cash after subtracting total debt.
  • Dilution risk is low, but the absence of detailed dilution rationales limits capital structure analysis.
  • The lack of recent events or disclosures suggests a stable but uneventful operational environment.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$472.4M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$176.1M
CapEx-$16.7M
Free cash flow
Total assets
Total liabilities$2.50B
Total equity$928.3M
Cash & equivalents
Long-term debt$1.41B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$1.41B
Current ratio
Debt/Equity1.5
ROA
ROE
Cash conversion
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002360Activity
Op margin0.4% medp25 -8.0% · p75 16.0%
Net margin2.3% medp25 -11.6% · p75 11.8%
Gross margin20.8% medp25 14.9% · p75 24.0%
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity152.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 15:45 UTC#310fae0c
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 11:12 UTCJob: 09e9a85b